Fri, January 6, 2023

Yasmeen Rahimi Upgraded (ALGS) to Buy and Increased Target to $75 on, Jan 6th, 2023

Yasmeen Rahimi of Piper Sandler, Upgraded "Aligos Therapeutics, Inc." (ALGS) to Buy and Increased Target from $50 to $75 on, Jan 6th, 2023.

Yasmeen has made no other calls on ALGS in the last 4 months.



There is 1 other peer that has a rating on ALGS. Out of the 1 peers that are also analyzing ALGS, all agrees with Yasmeen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Roanna Ruiz of "SVB Leerink" Maintained at Hold with Decreased Target to $50 on, Thursday, November 3rd, 2022